首页 > 最新文献

BioMed Research International最新文献

英文 中文
RETRACTION: Effect and Mechanism of Total Flavonoids Extracted from Cotinus Coggygria against Glioblastoma Cancer in Vitro and in Vivo. 摘要:黄连总黄酮体外和体内抗胶质母细胞瘤的作用及机制。
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-18 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/9857978
BioMed Research International

[This retracts the article DOI: 10.1155/2015/856349.].

[本文撤回文章DOI: 10.1155/2015/856349.]
{"title":"RETRACTION: Effect and Mechanism of Total Flavonoids Extracted from <i>Cotinus Coggygria</i> against Glioblastoma Cancer <i>in Vitro</i> and <i>in Vivo</i>.","authors":"BioMed Research International","doi":"10.1155/bmri/9857978","DOIUrl":"10.1155/bmri/9857978","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2015/856349.].</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"9857978"},"PeriodicalIF":2.3,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12714536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145803122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioinformatics Analysis of Hypoxia-Related Mechanisms in Endometriosis: DDR2 as a Potential Diagnostic and Therapeutic Biomarker. 子宫内膜异位症缺氧相关机制的生物信息学分析:DDR2作为一种潜在的诊断和治疗生物标志物。
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-18 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/4765791
Mingqi Zhao, Panpan Zhao, Caiyi Wang, Dan Ren, Yuxia Song, Xiaoqin Lu

Background: Endometriosis is a chronic gynecological disorder characterized by the presence of endometrial-like tissue outside the uterine cavity, causing chronic pain and infertility. Hypoxia plays a significant role in the progression of endometriosis.

Methods: We performed bioinformatics analysis on GEO datasets to identify differentially expressed genes (DEGs) in endometriosis, using weighted gene coexpression network analysis (WGCNA)and GeneCards for hypoxia-related genes. Machine learning models identified key hub genes. CCK-8, EdU, and Transwell assays assessed cell proliferation, migration, and invasion. Molecular docking was performed to investigate the interactions between the drug and the protein.

Results: In the GEO dataset analysis, 2834 DEGs were identified. Using WGCNA, a green module strongly correlated with endometriosis was identified. Intersecting this module with the hypoxia-related genes resulted in the selection of 449 key genes. Machine learning models, including support vector machines (SVMs), were employed to identify hypoxia-related DEGs with significant predictive value. LASSO and SVM-RFE were used to refine this list, ultimately selecting six hub genes: DDR2, ENO3, ESM1, NMBR, PRKAB1, and PRPF19. Validation with an independent dataset confirmed DDR2 as a promising diagnostic biomarker. Functional assays demonstrated that DDR2 knockdown significantly inhibited cell proliferation, migration, and invasion in the endometriosis cell lines VK2/E6E7 and 12Z. DDR2, a receptor tyrosine kinase, mediates extracellular matrix remodeling and cell invasion under hypoxia. By interacting with collagen and HIFs, DDR2 activates pathways that promote MMP secretion, angiogenesis, and migration, facilitating endometriotic cell progression in the hypoxic microenvironment. Molecular docking identified key amino acids near DDR2's binding pocket that form hydrophobic interactions, hydrogen bonds, and π-stacking with baicalein, cavidine, sitogluside, and stigmasterol, further supporting DDR2's potential as a therapeutic target.

Conclusion: DDR2 is a key hypoxia-related gene in endometriosis and a promising diagnostic and therapeutic biomarker.

背景:子宫内膜异位症是一种慢性妇科疾病,其特征是子宫腔外存在子宫内膜样组织,导致慢性疼痛和不孕。缺氧在子宫内膜异位症的进展中起着重要作用。方法:我们对GEO数据集进行生物信息学分析,以确定子宫内膜异位症的差异表达基因(DEGs),使用加权基因共表达网络分析(WGCNA)和GeneCards对缺氧相关基因进行分析。机器学习模型确定了关键的枢纽基因。CCK-8、EdU和Transwell检测评估细胞增殖、迁移和侵袭。分子对接是为了研究药物和蛋白质之间的相互作用。结果:在GEO数据集分析中,鉴定出2834个deg。使用WGCNA,我们发现了一个与子宫内膜异位症密切相关的绿色模块。将该模块与缺氧相关基因交叉,筛选出449个关键基因。采用支持向量机(svm)等机器学习模型识别具有显著预测价值的缺氧相关deg。利用LASSO和SVM-RFE对该列表进行细化,最终筛选出6个枢纽基因:DDR2、ENO3、ESM1、NMBR、PRKAB1和PRPF19。独立数据集验证证实DDR2是一种有前景的诊断性生物标志物。功能分析表明,DDR2敲低可显著抑制子宫内膜异位症细胞系VK2/E6E7和12Z细胞的增殖、迁移和侵袭。DDR2是一种酪氨酸激酶受体,在缺氧条件下介导细胞外基质重塑和细胞侵袭。通过与胶原蛋白和hif相互作用,DDR2激活促进MMP分泌、血管生成和迁移的途径,促进子宫内膜异位症细胞在缺氧微环境中的进展。分子对接发现了DDR2结合袋附近的关键氨基酸,这些氨基酸与黄黄素、cavidine、sitogluside和stigmastrol形成疏水相互作用、氢键和π堆积,进一步支持了DDR2作为治疗靶点的潜力。结论:DDR2是子宫内膜异位症的关键缺氧相关基因,是一种有前景的诊断和治疗生物标志物。
{"title":"Bioinformatics Analysis of Hypoxia-Related Mechanisms in Endometriosis: DDR2 as a Potential Diagnostic and Therapeutic Biomarker.","authors":"Mingqi Zhao, Panpan Zhao, Caiyi Wang, Dan Ren, Yuxia Song, Xiaoqin Lu","doi":"10.1155/bmri/4765791","DOIUrl":"10.1155/bmri/4765791","url":null,"abstract":"<p><strong>Background: </strong>Endometriosis is a chronic gynecological disorder characterized by the presence of endometrial-like tissue outside the uterine cavity, causing chronic pain and infertility. Hypoxia plays a significant role in the progression of endometriosis.</p><p><strong>Methods: </strong>We performed bioinformatics analysis on GEO datasets to identify differentially expressed genes (DEGs) in endometriosis, using weighted gene coexpression network analysis (WGCNA)and GeneCards for hypoxia-related genes. Machine learning models identified key hub genes. CCK-8, EdU, and Transwell assays assessed cell proliferation, migration, and invasion. Molecular docking was performed to investigate the interactions between the drug and the protein.</p><p><strong>Results: </strong>In the GEO dataset analysis, 2834 DEGs were identified. Using WGCNA, a green module strongly correlated with endometriosis was identified. Intersecting this module with the hypoxia-related genes resulted in the selection of 449 key genes. Machine learning models, including support vector machines (SVMs), were employed to identify hypoxia-related DEGs with significant predictive value. LASSO and SVM-RFE were used to refine this list, ultimately selecting six hub genes: DDR2, ENO3, ESM1, NMBR, PRKAB1, and PRPF19. Validation with an independent dataset confirmed DDR2 as a promising diagnostic biomarker. Functional assays demonstrated that DDR2 knockdown significantly inhibited cell proliferation, migration, and invasion in the endometriosis cell lines VK2/E6E7 and 12Z. DDR2, a receptor tyrosine kinase, mediates extracellular matrix remodeling and cell invasion under hypoxia. By interacting with collagen and HIFs, DDR2 activates pathways that promote MMP secretion, angiogenesis, and migration, facilitating endometriotic cell progression in the hypoxic microenvironment. Molecular docking identified key amino acids near DDR2's binding pocket that form hydrophobic interactions, hydrogen bonds, and <i>π</i>-stacking with baicalein, cavidine, sitogluside, and stigmasterol, further supporting DDR2's potential as a therapeutic target.</p><p><strong>Conclusion: </strong>DDR2 is a key hypoxia-related gene in endometriosis and a promising diagnostic and therapeutic biomarker.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"4765791"},"PeriodicalIF":2.3,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12714822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145803113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Burden of Cancer in Wolaita Zone, Ethiopia: A Retrospective Pathology-Based Analysis. 在Wolaita地区的癌症患病率和负担,埃塞俄比亚:回顾性病理为基础的分析。
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-17 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/9923869
Desta Seba Burka, Tamrat Balcha Balla, Temesgen Tesfaye Ajabo

Background: Despite the increasing incidence of cancer worldwide, the knowledge about the trend of cancer incidence in Ethiopia is limited. The paucity of core cancer diagnostic services like pathology, diagnostic imaging technology, and the absence of a comprehensive national cancer registry masked the exact magnitude of cancer incidence in Ethiopia in general and the Wolaita area in particular. This study is aimed at filling the gap by analyzing diagnostic data from a referral clinic. The clinic used to serve as a primary diagnostic center for patients referred from over 25 healthcare facilities in the region.

Methods: A pathology sample retrospective analysis-based prevalence study was conducted for the period between December 2017 and February 2022. Records saved in computers were subjected to analysis by using Statistical Package for Social Sciences (SPSS) software Version 22. The data were used to analyze the types and distribution of cancers in the region across age, sex, and diagnosis.

Results and discussions: The results showed notable gender disparities, with women experiencing a greater prevalence of breast cancer and men mostly receiving diagnoses for soft tissue sarcomas. The most prevalent forms of cancer were determined, along with the locations of each. The study also emphasized how different referral facilities, such as general hospitals, primary hospitals, and medium-sized clinics, had varying cancer incidence rates. Although generalizability may be limited by the study's clinic-based design, its relevance to comparable healthcare settings in Ethiopia and other low-resource locations is strengthened by the large and diverse sample drawn from a variety of referral institutions. This study emphasizes the necessity of focused screening programs and greater cancer awareness in Wolaita Zone, particularly in rural regions. The results also suggest possible directions for future investigation, such as population-based studies to confirm and build upon these findings.

Conclusions: This study provides crucial insights into the cancer burden in Wolaita Zone and emphasizes the importance of improving diagnostic and preventive measures. Further research, including broader, population-based studies, is necessary to confirm these findings and inform regional cancer control strategies.

背景:尽管世界范围内癌症发病率不断上升,但对埃塞俄比亚癌症发病率趋势的了解有限。核心癌症诊断服务,如病理学、诊断成像技术的缺乏,以及缺乏全面的国家癌症登记,掩盖了埃塞俄比亚,特别是Wolaita地区癌症发病率的确切程度。本研究旨在通过分析转诊诊所的诊断数据来填补这一空白。该诊所过去是该地区超过25家医疗机构转诊患者的初级诊断中心。方法:2017年12月至2022年2月,采用病理样本回顾性分析的流行病学研究。保存在计算机中的记录使用SPSS (Statistical Package for Social Sciences)第22版软件进行分析。这些数据被用来分析该地区癌症的类型和分布,包括年龄、性别和诊断。结果和讨论:结果显示了明显的性别差异,女性患乳腺癌的比例更高,而男性大多被诊断为软组织肉瘤。确定了最常见的癌症类型,以及每种类型的位置。该研究还强调了不同的转诊机构,如综合医院、初级医院和中型诊所,如何有不同的癌症发病率。尽管该研究的普遍性可能受到基于诊所的设计的限制,但从各种转诊机构抽取的大量不同样本加强了其与埃塞俄比亚和其他低资源地区可比医疗保健环境的相关性。这项研究强调了在Wolaita地区,特别是在农村地区,重点筛查项目和提高癌症意识的必要性。这些结果还为未来的调查指明了可能的方向,例如以人群为基础的研究来证实和建立这些发现。结论:本研究对Wolaita地区的癌症负担提供了重要的见解,并强调了改进诊断和预防措施的重要性。需要进一步的研究,包括更广泛的、基于人群的研究,以证实这些发现并为区域癌症控制战略提供信息。
{"title":"Prevalence and Burden of Cancer in Wolaita Zone, Ethiopia: A Retrospective Pathology-Based Analysis.","authors":"Desta Seba Burka, Tamrat Balcha Balla, Temesgen Tesfaye Ajabo","doi":"10.1155/bmri/9923869","DOIUrl":"10.1155/bmri/9923869","url":null,"abstract":"<p><strong>Background: </strong>Despite the increasing incidence of cancer worldwide, the knowledge about the trend of cancer incidence in Ethiopia is limited. The paucity of core cancer diagnostic services like pathology, diagnostic imaging technology, and the absence of a comprehensive national cancer registry masked the exact magnitude of cancer incidence in Ethiopia in general and the Wolaita area in particular. This study is aimed at filling the gap by analyzing diagnostic data from a referral clinic. The clinic used to serve as a primary diagnostic center for patients referred from over 25 healthcare facilities in the region.</p><p><strong>Methods: </strong>A pathology sample retrospective analysis-based prevalence study was conducted for the period between December 2017 and February 2022. Records saved in computers were subjected to analysis by using Statistical Package for Social Sciences (SPSS) software Version 22. The data were used to analyze the types and distribution of cancers in the region across age, sex, and diagnosis.</p><p><strong>Results and discussions: </strong>The results showed notable gender disparities, with women experiencing a greater prevalence of breast cancer and men mostly receiving diagnoses for soft tissue sarcomas. The most prevalent forms of cancer were determined, along with the locations of each. The study also emphasized how different referral facilities, such as general hospitals, primary hospitals, and medium-sized clinics, had varying cancer incidence rates. Although generalizability may be limited by the study's clinic-based design, its relevance to comparable healthcare settings in Ethiopia and other low-resource locations is strengthened by the large and diverse sample drawn from a variety of referral institutions. This study emphasizes the necessity of focused screening programs and greater cancer awareness in Wolaita Zone, particularly in rural regions. The results also suggest possible directions for future investigation, such as population-based studies to confirm and build upon these findings.</p><p><strong>Conclusions: </strong>This study provides crucial insights into the cancer burden in Wolaita Zone and emphasizes the importance of improving diagnostic and preventive measures. Further research, including broader, population-based studies, is necessary to confirm these findings and inform regional cancer control strategies.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"9923869"},"PeriodicalIF":2.3,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting SIRT1: A Potential Strategy for Combating Severe COVID-19. 靶向SIRT1:对抗重症COVID-19的潜在策略
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-17 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/9507417
Hajar Shokri-Afra, Fatemeh Saber Jeyvan, Zeinab Barartabar, Parisa Khanicheragh, Elham Yousefi Abdolmaleki, Davod Ilbeigi, Hadis Musavi, Yalda Malekzadegan

Sirtuin 1 (SIRT1) is a crucial regulator of cellular processes, including inflammation, metabolism, and stress responses, playing a significant role in the body's defense mechanisms. During SARS-CoV-2 infection, SIRT1 plays a crucial role in modulating the immune response. This protein helps to enhance the antiviral response through deacetylating key transcription factors and regulating proinflammatory cytokines, thereby reducing the cytokine storm (an overwhelming immune response) associated with severe COVID-19 cases. SIRT1 influences the expression of angiotensin-converting enzyme 2 (ACE2), the primary receptor for SARS-CoV-2, thereby potentially mitigating viral entry and replication. Natural activators of SIRT1, such as resveratrol, have been shown to enhance its activity, offering promising avenues for therapeutic interventions aimed at bolstering the immune response during COVID-19. Understanding the multifaceted role of SIRT1 in human defense mechanisms against SARS-CoV-2 could pave the way for innovative strategies to manage COVID-19 and similar viral infections, emphasizing the importance of SIRT1 as a potential target for future therapeutic approaches.

Sirtuin 1 (SIRT1)是细胞过程的重要调节因子,包括炎症、代谢和应激反应,在身体的防御机制中发挥重要作用。在SARS-CoV-2感染期间,SIRT1在调节免疫反应中起着至关重要的作用。该蛋白有助于通过去乙酰化关键转录因子和调节促炎细胞因子来增强抗病毒反应,从而减少与COVID-19重症病例相关的细胞因子风暴(压倒性免疫反应)。SIRT1影响血管紧张素转换酶2 (ACE2)的表达,ACE2是SARS-CoV-2的主要受体,从而可能减缓病毒的进入和复制。SIRT1的天然激活剂,如白藜芦醇,已被证明可以增强其活性,为旨在增强COVID-19期间免疫反应的治疗干预提供了有希望的途径。了解SIRT1在人类对SARS-CoV-2的防御机制中的多方面作用,可以为管理COVID-19和类似病毒感染的创新策略铺平道路,强调SIRT1作为未来治疗方法的潜在靶点的重要性。
{"title":"Targeting SIRT1: A Potential Strategy for Combating Severe COVID-19.","authors":"Hajar Shokri-Afra, Fatemeh Saber Jeyvan, Zeinab Barartabar, Parisa Khanicheragh, Elham Yousefi Abdolmaleki, Davod Ilbeigi, Hadis Musavi, Yalda Malekzadegan","doi":"10.1155/bmri/9507417","DOIUrl":"10.1155/bmri/9507417","url":null,"abstract":"<p><p>Sirtuin 1 (SIRT1) is a crucial regulator of cellular processes, including inflammation, metabolism, and stress responses, playing a significant role in the body's defense mechanisms. During SARS-CoV-2 infection, SIRT1 plays a crucial role in modulating the immune response. This protein helps to enhance the antiviral response through deacetylating key transcription factors and regulating proinflammatory cytokines, thereby reducing the cytokine storm (an overwhelming immune response) associated with severe COVID-19 cases. SIRT1 influences the expression of angiotensin-converting enzyme 2 (ACE2), the primary receptor for SARS-CoV-2, thereby potentially mitigating viral entry and replication. Natural activators of SIRT1, such as resveratrol, have been shown to enhance its activity, offering promising avenues for therapeutic interventions aimed at bolstering the immune response during COVID-19. Understanding the multifaceted role of SIRT1 in human defense mechanisms against SARS-CoV-2 could pave the way for innovative strategies to manage COVID-19 and similar viral infections, emphasizing the importance of SIRT1 as a potential target for future therapeutic approaches.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"9507417"},"PeriodicalIF":2.3,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering B Cell Heterogeneity and Pathogenic Mechanisms in Osteoporosis Through Single-Cell RNA Sequencing. 通过单细胞RNA测序解读骨质疏松症的B细胞异质性和致病机制。
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-14 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/9979105
Taolve Zhou, Jiayuan Zheng, Yujun Sun, Jionglin Wu, Wenzhou Liu, Zhenxiang Zheng, Jiajie Li, Guo Fu, Fan Zhang, Yanbo Chen, Gang Zeng, Weidong Song

Background: Osteoporosis is characterized by reduced bone mineral density and disrupted bone microstructure, leading to an increased risk of fractures. This study aimed to investigate the role of B cell subpopulations in osteoporosis and their effects on bone metabolism using single-cell RNA sequencing.

Methods: Single-cell RNA sequencing data from primary human femoral head tissue cells of three osteoporosis patients and one non-osteoporosis patient were obtained from the GEO dataset (GSE169396). Data preprocessing, integration, dimensionality reduction, clustering, and annotation were conducted using the Seurat package in R. Enrichment analysis, cell trajectory analysis, and intercellular communication analysis were then applied to investigate the role of B cells and the signaling pathways within B cell subpopulations in osteoporosis.

Results: We identified six distinct B cell subpopulations, and further analysis revealed a higher proportion of precursor B cells in osteoporosis patients compared to the normal group. Functional studies indicated that B cells contribute to the progression of osteoporosis through inflammatory activation and the unfolded protein response. Cell communication analysis among these B cell subpopulations demonstrated markedly enhanced intercellular signaling in osteoporosis patients relative to the normal group. Notably, two critical signaling pathways, MIF-(CD74+CXCR4) and LGALS9-CD45, were identified as potential key regulators driving the progression of osteoporosis.

Conclusion: This study underscores the heterogeneity and functions of B cells in osteoporosis, highlighting two signaling pathways implicated in disease progression. These findings offer novel insights into osteoporosis pathogenesis and suggest potential therapeutic targets for its treatment.

背景:骨质疏松症的特点是骨密度降低和骨微观结构破坏,导致骨折的风险增加。本研究旨在利用单细胞RNA测序技术研究B细胞亚群在骨质疏松症中的作用及其对骨代谢的影响。方法:从GEO数据集(GSE169396)中获取3例骨质疏松症患者和1例非骨质疏松症患者的原代人股骨头组织细胞的单细胞RNA测序数据。利用Seurat软件包进行数据预处理、整合、降维、聚类和注释,然后利用富集分析、细胞轨迹分析和细胞间通讯分析来研究B细胞及其亚群在骨质疏松症中的作用和信号通路。结果:我们确定了六个不同的B细胞亚群,进一步的分析显示,与正常组相比,骨质疏松症患者中前体B细胞的比例更高。功能研究表明,B细胞通过炎症激活和未折叠蛋白反应参与骨质疏松症的进展。这些B细胞亚群之间的细胞通讯分析表明,与正常组相比,骨质疏松症患者的细胞间信号传导明显增强。值得注意的是,两个关键信号通路MIF-(CD74+CXCR4)和LGALS9-CD45被确定为驱动骨质疏松症进展的潜在关键调节因子。结论:本研究强调了B细胞在骨质疏松症中的异质性和功能,强调了与疾病进展有关的两种信号通路。这些发现为骨质疏松的发病机制提供了新的见解,并为其治疗提供了潜在的治疗靶点。
{"title":"Deciphering B Cell Heterogeneity and Pathogenic Mechanisms in Osteoporosis Through Single-Cell RNA Sequencing.","authors":"Taolve Zhou, Jiayuan Zheng, Yujun Sun, Jionglin Wu, Wenzhou Liu, Zhenxiang Zheng, Jiajie Li, Guo Fu, Fan Zhang, Yanbo Chen, Gang Zeng, Weidong Song","doi":"10.1155/bmri/9979105","DOIUrl":"10.1155/bmri/9979105","url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is characterized by reduced bone mineral density and disrupted bone microstructure, leading to an increased risk of fractures. This study aimed to investigate the role of B cell subpopulations in osteoporosis and their effects on bone metabolism using single-cell RNA sequencing.</p><p><strong>Methods: </strong>Single-cell RNA sequencing data from primary human femoral head tissue cells of three osteoporosis patients and one non-osteoporosis patient were obtained from the GEO dataset (GSE169396). Data preprocessing, integration, dimensionality reduction, clustering, and annotation were conducted using the Seurat package in R. Enrichment analysis, cell trajectory analysis, and intercellular communication analysis were then applied to investigate the role of B cells and the signaling pathways within B cell subpopulations in osteoporosis.</p><p><strong>Results: </strong>We identified six distinct B cell subpopulations, and further analysis revealed a higher proportion of precursor B cells in osteoporosis patients compared to the normal group. Functional studies indicated that B cells contribute to the progression of osteoporosis through inflammatory activation and the unfolded protein response. Cell communication analysis among these B cell subpopulations demonstrated markedly enhanced intercellular signaling in osteoporosis patients relative to the normal group. Notably, two critical signaling pathways, MIF-(CD74+CXCR4) and LGALS9-CD45, were identified as potential key regulators driving the progression of osteoporosis.</p><p><strong>Conclusion: </strong>This study underscores the heterogeneity and functions of B cells in osteoporosis, highlighting two signaling pathways implicated in disease progression. These findings offer novel insights into osteoporosis pathogenesis and suggest potential therapeutic targets for its treatment.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"9979105"},"PeriodicalIF":2.3,"publicationDate":"2025-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12703134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145767270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revolutionizing Lung Cancer Detection: A High-Accuracy Machine Learning Framework for Early Diagnosis. 革命性的肺癌检测:用于早期诊断的高精度机器学习框架。
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-12 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/9961773
Tahir Muhammad Ali, Azka Mir, Attique Ur Rehman, Mamoona Humayun, Momina Shaheen, Rafeef Taresh Suliman Alshammari

Lung cancer is a deadly disease. According to a report of 2024, it is the primary reason for 1.82 million deaths. Given the high disease burden, early detection of lung cancer is crucial for improving survival rates and implementing effective strategies. This paper is aimed at conducting a systematic literature review and developing a highly accurate framework for predicting lung cancer effectively. Tollgate methodology has been used for systematic literature review, and quality assessment criteria were applied to select published articles relevant to the research questions. The paper investigates the effectiveness of machine learning in identifying patterns relevant to lung cancer prediction (Q1), examines the pros and cons of current predictive systems (Q2), compares the use of artificial intelligence in lung cancer prediction with traditional methods (Q3), and identifies key features that distinguish lung cancer from patient symptoms (Q4). Machine learning techniques were employed for the proposed framework. Two publicly available, distinct datasets containing clinical features were obtained. Then, the SelectKBest method was used for feature selection, and SMOTE was used to handle class imbalance. Our proposed framework includes a voting ensemble with random forest, support vector machine, and logistic regression with cross-validation. The results indicate an accuracy of 99% and 92.5% for the first and second datasets, respectively. This study's systematic literature review, based on four research questions and a machine learning model, exhibits high accuracy in predicting lung cancer.

肺癌是一种致命的疾病。根据2024年的一份报告,它是182万人死亡的主要原因。鉴于疾病负担高,早期发现肺癌对于提高生存率和实施有效战略至关重要。本文旨在进行系统的文献综述,并建立一个高度准确的有效预测肺癌的框架。采用收费门方法进行系统文献综述,并采用质量评价标准选择与研究问题相关的已发表文章。本文研究了机器学习在识别肺癌预测相关模式方面的有效性(Q1),研究了当前预测系统的优缺点(Q2),比较了人工智能在肺癌预测中的使用与传统方法(Q3),并确定了区分肺癌和患者症状的关键特征(Q4)。提出的框架采用了机器学习技术。获得了两个公开可用的、不同的包含临床特征的数据集。然后,使用SelectKBest方法进行特征选择,使用SMOTE方法处理类不平衡。我们提出的框架包括随机森林、支持向量机和交叉验证逻辑回归的投票集成。结果表明,第一和第二数据集的准确率分别为99%和92.5%。本研究基于四个研究问题和一个机器学习模型进行了系统的文献综述,在预测肺癌方面显示出很高的准确性。
{"title":"Revolutionizing Lung Cancer Detection: A High-Accuracy Machine Learning Framework for Early Diagnosis.","authors":"Tahir Muhammad Ali, Azka Mir, Attique Ur Rehman, Mamoona Humayun, Momina Shaheen, Rafeef Taresh Suliman Alshammari","doi":"10.1155/bmri/9961773","DOIUrl":"10.1155/bmri/9961773","url":null,"abstract":"<p><p>Lung cancer is a deadly disease. According to a report of 2024, it is the primary reason for 1.82 million deaths. Given the high disease burden, early detection of lung cancer is crucial for improving survival rates and implementing effective strategies. This paper is aimed at conducting a systematic literature review and developing a highly accurate framework for predicting lung cancer effectively. Tollgate methodology has been used for systematic literature review, and quality assessment criteria were applied to select published articles relevant to the research questions. The paper investigates the effectiveness of machine learning in identifying patterns relevant to lung cancer prediction (Q1), examines the pros and cons of current predictive systems (Q2), compares the use of artificial intelligence in lung cancer prediction with traditional methods (Q3), and identifies key features that distinguish lung cancer from patient symptoms (Q4). Machine learning techniques were employed for the proposed framework. Two publicly available, distinct datasets containing clinical features were obtained. Then, the SelectKBest method was used for feature selection, and SMOTE was used to handle class imbalance. Our proposed framework includes a voting ensemble with random forest, support vector machine, and logistic regression with cross-validation. The results indicate an accuracy of 99% and 92.5% for the first and second datasets, respectively. This study's systematic literature review, based on four research questions and a machine learning model, exhibits high accuracy in predicting lung cancer.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"9961773"},"PeriodicalIF":2.3,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12699974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145755051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healing Oral Mucositis With Arrabidaea chica Verlot Mucoadhesive Gel in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Controlled Clinical Trial. 一项随机对照临床试验:中国紫檀黏附凝胶治疗造血干细胞移植患者口腔黏膜炎。
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-12 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/3700170
Núbia de Cássia Almeida Queiroz, Ilza Maria de Oliveira Sousa, Rogério José Machado Júnior, Afonso Celso Vigorito, Elida Adriana de Castro Aranha, Andressa Gomes Melo, João Ernesto de Carvalho, Mary Ann Foglio

Introduction: Oral mucositis affects up to 80% of patients undergoing bone marrow transplantation, causing painful ulcers, increased infection risk, and impaired quality of life. Current treatments are mainly palliative, highlighting the need for new therapeutic options. Arrabidaea chica Verlot extract has shown wound healing potential through antioxidant activity and collagen synthesis promotion in vitro and significant wound area reduction in vivo.

Objective: The objective of the study is to evaluate the wound healing potential of a mucoadhesive gel containing 2.5% A. chica extract for treating oral mucositis in oncohematological patients undergoing bone marrow transplantation.

Methods: This was a randomized, controlled, open-label, parallel-group clinical trial conducted at HC/UNICAMP from October 2022 to November 2024. Forty-four patients were randomized to the intervention group (mucoadhesive A. chica gel, n = 22) or control group (low-intensity laser therapy, n = 22). The primary outcome was the time to healing of oral mucositis. Statistical analysis compared mean healing times between groups.

Results: Twenty participants in the intervention group and 18 in the control group completed the study. Mean healing time was 5.2 ± 1.5 days for the intervention group and 11.2 ± 6.5 days for the control group, representing a 2.2-fold faster healing with A. chica gel. Some intervention participants reported a mild burning sensation, without affecting treatment adherence or efficacy.

Conclusion: The mucoadhesive gel containing A. chica extract proved to be a safe and effective therapeutic option for treating oral mucositis in patients undergoing bone marrow transplantation.

Trial registration: ReBEC number: RBR-5×4397.

口腔黏膜炎影响多达80%的骨髓移植患者,引起疼痛性溃疡、感染风险增加和生活质量下降。目前的治疗主要是姑息性的,因此需要新的治疗方案。紫菀提取物在体外具有抗氧化活性,促进胶原合成,并在体内显著减少创面面积,显示出伤口愈合潜力。目的:本研究的目的是评估含有2.5%赤曲霉提取物的黏附凝胶治疗骨髓移植肿瘤血液病患者口腔黏膜炎的伤口愈合潜力。方法:这是一项随机、对照、开放标签、平行组临床试验,于2022年10月至2024年11月在HC/UNICAMP进行。44例患者随机分为干预组(胶黏法)和对照组(低强度激光治疗)。主要观察指标为口腔黏膜炎愈合时间。统计学分析比较各组平均愈合时间。结果:干预组20人,对照组18人完成研究。干预组的平均愈合时间为5.2±1.5天,对照组的平均愈合时间为11.2±6.5天,比对照组的愈合时间快2.2倍。一些干预参与者报告有轻微的烧灼感,但不影响治疗依从性或疗效。结论:中药乳香提取物黏附凝胶是一种安全有效的治疗骨髓移植患者口腔黏膜炎的方法。试验注册:ReBEC号:RBR-5×4397。
{"title":"Healing Oral Mucositis With <i>Arrabidaea chica</i> Verlot Mucoadhesive Gel in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Controlled Clinical Trial.","authors":"Núbia de Cássia Almeida Queiroz, Ilza Maria de Oliveira Sousa, Rogério José Machado Júnior, Afonso Celso Vigorito, Elida Adriana de Castro Aranha, Andressa Gomes Melo, João Ernesto de Carvalho, Mary Ann Foglio","doi":"10.1155/bmri/3700170","DOIUrl":"10.1155/bmri/3700170","url":null,"abstract":"<p><strong>Introduction: </strong>Oral mucositis affects up to 80% of patients undergoing bone marrow transplantation, causing painful ulcers, increased infection risk, and impaired quality of life. Current treatments are mainly palliative, highlighting the need for new therapeutic options. <i>Arrabidaea chica</i> Verlot extract has shown wound healing potential through antioxidant activity and collagen synthesis promotion in vitro and significant wound area reduction in vivo.</p><p><strong>Objective: </strong>The objective of the study is to evaluate the wound healing potential of a mucoadhesive gel containing 2.5% <i>A. chica</i> extract for treating oral mucositis in oncohematological patients undergoing bone marrow transplantation.</p><p><strong>Methods: </strong>This was a randomized, controlled, open-label, parallel-group clinical trial conducted at HC/UNICAMP from October 2022 to November 2024. Forty-four patients were randomized to the intervention group (mucoadhesive <i>A. chica</i> gel, <i>n</i> = 22) or control group (low-intensity laser therapy, <i>n</i> = 22). The primary outcome was the time to healing of oral mucositis. Statistical analysis compared mean healing times between groups.</p><p><strong>Results: </strong>Twenty participants in the intervention group and 18 in the control group completed the study. Mean healing time was 5.2 ± 1.5 days for the intervention group and 11.2 ± 6.5 days for the control group, representing a 2.2-fold faster healing with <i>A. chica</i> gel. Some intervention participants reported a mild burning sensation, without affecting treatment adherence or efficacy.</p><p><strong>Conclusion: </strong>The mucoadhesive gel containing <i>A. chica</i> extract proved to be a safe and effective therapeutic option for treating oral mucositis in patients undergoing bone marrow transplantation.</p><p><strong>Trial registration: </strong>ReBEC number: RBR-5×4397.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"3700170"},"PeriodicalIF":2.3,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12699320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145755063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antitumor Effects of Chemlali and Wild Olive Tree Extracts: Role in Cell Proliferation and Apoptosis in Prostate (PC3) and Breast (MDA-MB-231) Cancer Cell Lines. Chemlali和野生橄榄树提取物的抗肿瘤作用:在前列腺(PC3)和乳腺(MDA-MB-231)癌细胞增殖和凋亡中的作用
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-11 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/4911257
Radhia Bouazizi, Lamjed Bouslama, Fatma Nouira, Alice Grossi, Mattia De Vita, Bechir Baccouri, Selim Jallouli, Samantha Solito, Monica Savio, Virginie Sottile, Leila Abaza

Cancer remains a major global health challenge, requiring natural therapeutic solutions. Olive tree by-products, like leaves and pomace, are rich in bioactive phenolics with antioxidant and anticancer potential. This study explores the chemical composition and anticancer potential of the hexane fraction of olive leaf extracts and the dichloromethane fraction of olive pomace extracts from two Olea europaea varieties: e cultivated Chemlali (var. europaea) and the wild olive (var. sylvestris). GC-MS analysis identified stigmast-5-en-3-ol, erythrodiol, and phytol as the predominant compounds in wild olive leaf extracts, whereas Chemlali leaf extracts contained only the first two. Analysis of olive pomace extracts revealed four major compounds: coniferyl alcohol, glyceryl monooleate, stigmast-5-en-3-ol, and methylursolate, present in both varieties, with significant variations in their peak areas. Cytotoxic evaluation showed that olive waste extracts significantly inhibited cancer cell growth and viability in both prostate (PC3) and breast (MDA-MB-231) cancer cell lines. Specifically, pomace extracts exhibited the strongest effect against PC3 prostate cancer cells, while leaf extracts were more effective against MDA-MB-231 breast cancer cells. These extracts inhibited cell proliferation, induced morphological and phenotypic alterations, modified the cell cycle progression, promoted apoptotic nuclear changes, and triggered apoptosis. Notably, wild olive extracts demonstrated stronger cytotoxic effects than those derived from the Chemlali cultivar. These findings highlight olive by-products as promising sources of natural anticancer agents for pharmaceutical applications.

癌症仍然是一个重大的全球健康挑战,需要自然治疗解决方案。橄榄树的副产品,如树叶和果渣,富含具有抗氧化和抗癌潜力的生物活性酚类物质。研究了栽培橄榄(var. europaea)和野生橄榄(var. sylvestris)两种橄榄品种橄榄叶提取物的己烷部分和橄榄渣提取物的二氯甲烷部分的化学成分和抗癌潜力。GC-MS分析表明,野生橄榄叶提取物中主要含有柱头-5-烯-3-醇、红二醇和叶绿醇,而Chemlali叶提取物中只含有前两种化合物。对橄榄渣提取物的分析显示,两种品种中都存在四种主要化合物:松叶醇、单油酸甘油、5-烯-3-醇和熊果酸甲酯,它们的峰面积有显著差异。细胞毒性评价表明,橄榄废提取物显著抑制前列腺(PC3)和乳腺(MDA-MB-231)癌细胞的生长和活力。其中,果渣提取物对PC3前列腺癌细胞的抑制作用最强,而叶提取物对MDA-MB-231乳腺癌细胞的抑制作用更强。这些提取物抑制细胞增殖,诱导形态和表型改变,改变细胞周期进程,促进凋亡核改变,触发细胞凋亡。值得注意的是,野生橄榄提取物比Chemlali品种提取物表现出更强的细胞毒作用。这些发现强调了橄榄副产品作为天然抗癌药物应用的有前途的来源。
{"title":"Antitumor Effects of Chemlali and Wild Olive Tree Extracts: Role in Cell Proliferation and Apoptosis in Prostate (PC3) and Breast (MDA-MB-231) Cancer Cell Lines.","authors":"Radhia Bouazizi, Lamjed Bouslama, Fatma Nouira, Alice Grossi, Mattia De Vita, Bechir Baccouri, Selim Jallouli, Samantha Solito, Monica Savio, Virginie Sottile, Leila Abaza","doi":"10.1155/bmri/4911257","DOIUrl":"10.1155/bmri/4911257","url":null,"abstract":"<p><p>Cancer remains a major global health challenge, requiring natural therapeutic solutions. Olive tree by-products, like leaves and pomace, are rich in bioactive phenolics with antioxidant and anticancer potential. This study explores the chemical composition and anticancer potential of the hexane fraction of olive leaf extracts and the dichloromethane fraction of olive pomace extracts from two <i>Olea europaea</i> varieties: e cultivated Chemlali (var. <i>europaea</i>) and the wild olive (<i>var. sylvestris</i>). GC-MS analysis identified stigmast-5-en-3-ol, erythrodiol, and phytol as the predominant compounds in wild olive leaf extracts, whereas Chemlali leaf extracts contained only the first two. Analysis of olive pomace extracts revealed four major compounds: coniferyl alcohol, glyceryl monooleate, stigmast-5-en-3-ol, and methylursolate, present in both varieties, with significant variations in their peak areas. Cytotoxic evaluation showed that olive waste extracts significantly inhibited cancer cell growth and viability in both prostate (PC3) and breast (MDA-MB-231) cancer cell lines. Specifically, pomace extracts exhibited the strongest effect against PC3 prostate cancer cells, while leaf extracts were more effective against MDA-MB-231 breast cancer cells. These extracts inhibited cell proliferation, induced morphological and phenotypic alterations, modified the cell cycle progression, promoted apoptotic nuclear changes, and triggered apoptosis. Notably, wild olive extracts demonstrated stronger cytotoxic effects than those derived from the Chemlali cultivar. These findings highlight olive by-products as promising sources of natural anticancer agents for pharmaceutical applications.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"4911257"},"PeriodicalIF":2.3,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12699138/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145755024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenolic Compounds of Justicia gendarussa Show Pharmacological Potentials Against Pain, Oxidation, Hyperglycemia, Diarrhea, and Microbes: Phytopharmacological and Computational Approaches. 龙涎香的酚类化合物显示出抗疼痛、氧化、高血糖、腹泻和微生物的药理潜力:植物药理学和计算方法。
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-09 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/2561508
Farzana Akter Munny, Mehedi Islam, Mahafuza Akter, Mushtahsin Ferdousi, Md Moaz Ahmed Asif, Md Solaiman Hossain, Sabrina Sharmin, Md Zahidul Islam, Md Aslam Hossain, Md Rabiul Islam, Baisakhi Banerjee

Background: Justicia gendarussa is a branched shrub spread across Indian, Sri Lankan, and Malaysian forests. It has been widely used across many countries to treat asthma, rheumatism, colics in children, eczema, and HIV. The study goal was to investigate the phytoconstituents from J. gendarussa and to discover its therapeutic potential against various disease conditions.

Methods: The plant sample was collected, dried, and grinded into coarse powder which was then soaked in methanol for 2 weeks. After the maceration process, the crude methanolic extract was subjected to solvent-solvent partitioning into four different fractions: n-hexane soluble fraction (HSF), dichloromethane soluble fraction (DMSF), ethyl acetate soluble fraction (EASF), and aqueous fraction (AQF). DMSF was chemically evaluated through chromatographic separation, and all the fractions including the crude methanolic extracts were assessed for their potential pharmacological activities against pain, oxidative stress, hyperglycemia, diarrhea, and microbes following standard protocols.

Results: Chemical investigation results in the isolation of lupeol, β-sitosterol, and 1-monostearin. The structures of the compounds were elucidated through meticulous NMR spectroscopic analysis. In a DPPH free radical scavenging assay, prominent action was noticed by EASF, with a median inhibition concentration (IC50) of 24.207 g/mL in comparison to the BHT with an IC50 value of 23.159 g/mL. In central analgesic activity, all the results were highly significant, with the highest (233.47%) time elongation in comparison to the control, observed after 90 min at 600 mg/kg b.w. and maximum peripheral analgesic activity of 61.96% was found at a dose of 600 mg/kg b.w. Two test doses (600 and 400 mg/kg b.w.) demonstrated substantial hypoglycemic and antidiarrheal effects that became more pronounced over time. The isolated compounds demonstrated impressive binding scores when interacting with glutathione reductase (3GRS), mu-opioid receptor (MOR), kappa opioid receptor (KOR), and glucose transporter 3 (GLUT 3) receptors. However, their performance was notably lacking in terms of binding with cyclooxygenase-2 (COX-2) and dihydrofolate reductase (DHFR) receptors.

Conclusion: Three isolated phytochemicals demonstrate promising binding affinities with the receptor molecules that support the pharmacological findings of this study. However, additional research needs to be conducted to isolate more phytoconstituents and affirm the pharmacological potential of J. gendarussa.

背景:金darussa是一种分布在印度、斯里兰卡和马来西亚森林中的分枝灌木。它已在许多国家广泛用于治疗哮喘、风湿病、儿童绞痛、湿疹和艾滋病毒。本研究的目的是研究红豆杉的植物成分,并发现其对各种疾病的治疗潜力。方法:采集植物标本,干燥后磨成粗粉,甲醇浸泡2周。浸渍后,对粗甲醇提取物进行溶剂-溶剂分馏,分为正己烷可溶馏分(HSF)、二氯甲烷可溶馏分(DMSF)、乙酸乙酯可溶馏分(EASF)和水馏分(AQF)。通过色谱分离对DMSF进行化学评价,并根据标准方案评估所有馏分(包括粗甲醇提取物)对疼痛、氧化应激、高血糖、腹泻和微生物的潜在药理活性。结果:化学鉴定分离出芦皮醇、β-谷甾醇和1-单硬脂素。化合物的结构通过细致的核磁共振波谱分析得以阐明。在DPPH自由基清除实验中,EASF有明显的作用,其中位抑制浓度(IC50)为24.207 g/mL,而BHT的IC50值为23.159 g/mL。在中枢镇痛活性方面,所有结果都非常显著,与对照组相比,在600 mg/kg体重下观察到的时间延长率最高(233.47%),在600 mg/kg体重下观察到的最大外周镇痛活性为61.96%。两个试验剂量(600和400 mg/kg体重)显示出明显的降糖和止泻作用,随着时间的推移变得更加明显。分离的化合物在与谷胱甘肽还原酶(3GRS)、mu-阿片受体(MOR)、kappa阿片受体(KOR)和葡萄糖转运蛋白3 (GLUT 3)受体相互作用时表现出令人印象深刻的结合分数。然而,在与环氧化酶-2 (COX-2)和二氢叶酸还原酶(DHFR)受体的结合方面,它们的表现明显不足。结论:三种分离的植物化学物质显示出与受体分子的良好结合亲和力,支持本研究的药理学发现。然而,还需要进一步的研究来分离更多的植物成分,并确认龙胆草的药理潜力。
{"title":"Phenolic Compounds of <i>Justicia gendarussa</i> Show Pharmacological Potentials Against Pain, Oxidation, Hyperglycemia, Diarrhea, and Microbes: Phytopharmacological and Computational Approaches.","authors":"Farzana Akter Munny, Mehedi Islam, Mahafuza Akter, Mushtahsin Ferdousi, Md Moaz Ahmed Asif, Md Solaiman Hossain, Sabrina Sharmin, Md Zahidul Islam, Md Aslam Hossain, Md Rabiul Islam, Baisakhi Banerjee","doi":"10.1155/bmri/2561508","DOIUrl":"10.1155/bmri/2561508","url":null,"abstract":"<p><strong>Background: </strong><i>Justicia gendarussa</i> is a branched shrub spread across Indian, Sri Lankan, and Malaysian forests. It has been widely used across many countries to treat asthma, rheumatism, colics in children, eczema, and HIV. The study goal was to investigate the phytoconstituents from <i>J. gendarussa</i> and to discover its therapeutic potential against various disease conditions.</p><p><strong>Methods: </strong>The plant sample was collected, dried, and grinded into coarse powder which was then soaked in methanol for 2 weeks. After the maceration process, the crude methanolic extract was subjected to solvent-solvent partitioning into four different fractions: n-hexane soluble fraction (HSF), dichloromethane soluble fraction (DMSF), ethyl acetate soluble fraction (EASF), and aqueous fraction (AQF). DMSF was chemically evaluated through chromatographic separation, and all the fractions including the crude methanolic extracts were assessed for their potential pharmacological activities against pain, oxidative stress, hyperglycemia, diarrhea, and microbes following standard protocols.</p><p><strong>Results: </strong>Chemical investigation results in the isolation of lupeol, <i>β</i>-sitosterol, and 1-monostearin. The structures of the compounds were elucidated through meticulous NMR spectroscopic analysis. In a DPPH free radical scavenging assay, prominent action was noticed by EASF, with a median inhibition concentration (IC<sub>50</sub>) of 24.207 g/mL in comparison to the BHT with an IC<sub>50</sub> value of 23.159 g/mL. In central analgesic activity, all the results were highly significant, with the highest (233.47%) time elongation in comparison to the control, observed after 90 min at 600 mg/kg b.w. and maximum peripheral analgesic activity of 61.96% was found at a dose of 600 mg/kg b.w. Two test doses (600 and 400 mg/kg b.w.) demonstrated substantial hypoglycemic and antidiarrheal effects that became more pronounced over time. The isolated compounds demonstrated impressive binding scores when interacting with glutathione reductase (3GRS), mu-opioid receptor (MOR), kappa opioid receptor (KOR), and glucose transporter 3 (GLUT 3) receptors. However, their performance was notably lacking in terms of binding with cyclooxygenase-2 (COX-2) and dihydrofolate reductase (DHFR) receptors.</p><p><strong>Conclusion: </strong>Three isolated phytochemicals demonstrate promising binding affinities with the receptor molecules that support the pharmacological findings of this study. However, additional research needs to be conducted to isolate more phytoconstituents and affirm the pharmacological potential of <i>J. gendarussa</i>.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"2561508"},"PeriodicalIF":2.3,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12686832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145720888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Gene Signature-Based Prognostic Model for Patients With VEGF-Overexpressing Esophageal Squamous Cell Carcinoma. 基于基因特征的食管鳞状细胞癌患者预后新模型
IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2025-12-07 eCollection Date: 2025-01-01 DOI: 10.1155/bmri/5694628
Yonghui Li, Ruiyao Wang, Haibo Wang, Tingting Li, Cheng Long Zhang, Shaoyong Dong, Biao Zhang

Background and aims: The effects of vascular endothelial growth factor (VEGF) overexpression on the prognosis of patients with esophageal squamous cell carcinoma (ESCC) are still unclear. The aim of this study was to construct and evaluate a mutant gene-based model to predict the prognosis of ESCC patients with VEGF overexpression.

Methods: Samples from 50 ESCC patients with VEGF overexpression were subjected to next-generation sequencing (NGS) to identify gene mutations. The associations between the enrichment of these mutations and patient outcomes were also evaluated in a cohort from The Cancer Genome Atlas. Hazard ratios were identified via the Kaplan-Meier and Cox analyses. A support vector machine recursive feature elimination algorithm was used to construct the model, and receiver operating characteristic analysis was carried out to evaluate its prognostic performance.

Results: ESCC patients with FAT1, FGF3, FGF12, and FGF19 mutations; advanced M stage; and high neutrophil counts tended to have poorer prognoses.

Conclusion: A model based on a four-gene signature effectively predicts the prognosis of ESCC patients.

背景与目的:血管内皮生长因子(VEGF)过表达对食管鳞状细胞癌(ESCC)患者预后的影响尚不清楚。本研究的目的是构建并评估基于突变基因的模型来预测VEGF过表达ESCC患者的预后。方法:对50例VEGF过表达ESCC患者进行新一代测序(NGS)鉴定基因突变。这些突变的富集与患者预后之间的关系也在癌症基因组图谱的队列中进行了评估。通过Kaplan-Meier和Cox分析确定风险比。采用支持向量机递归特征消除算法构建模型,并进行接收机工作特征分析,评价其预测性能。结果:伴有FAT1、FGF3、FGF12和FGF19突变的ESCC患者;M期晚期;而嗜中性粒细胞计数高往往预后较差。结论:基于四基因标记的ESCC患者预后预测模型有效。
{"title":"New Gene Signature-Based Prognostic Model for Patients With VEGF-Overexpressing Esophageal Squamous Cell Carcinoma.","authors":"Yonghui Li, Ruiyao Wang, Haibo Wang, Tingting Li, Cheng Long Zhang, Shaoyong Dong, Biao Zhang","doi":"10.1155/bmri/5694628","DOIUrl":"10.1155/bmri/5694628","url":null,"abstract":"<p><strong>Background and aims: </strong>The effects of vascular endothelial growth factor (VEGF) overexpression on the prognosis of patients with esophageal squamous cell carcinoma (ESCC) are still unclear. The aim of this study was to construct and evaluate a mutant gene-based model to predict the prognosis of ESCC patients with VEGF overexpression.</p><p><strong>Methods: </strong>Samples from 50 ESCC patients with VEGF overexpression were subjected to next-generation sequencing (NGS) to identify gene mutations. The associations between the enrichment of these mutations and patient outcomes were also evaluated in a cohort from The Cancer Genome Atlas. Hazard ratios were identified via the Kaplan-Meier and Cox analyses. A support vector machine recursive feature elimination algorithm was used to construct the model, and receiver operating characteristic analysis was carried out to evaluate its prognostic performance.</p><p><strong>Results: </strong>ESCC patients with <i>FAT1</i>, <i>FGF3</i>, <i>FGF12</i>, and <i>FGF19</i> mutations; advanced M stage; and high neutrophil counts tended to have poorer prognoses.</p><p><strong>Conclusion: </strong>A model based on a four-gene signature effectively predicts the prognosis of ESCC patients.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"5694628"},"PeriodicalIF":2.3,"publicationDate":"2025-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12682582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BioMed Research International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1